Daily News header
Press Release

New Report Shows Women Who Choose Brookhaven Retreat Have Greater Success With Recovery

SEYMOUR, Tenn. - (BUSINESS WIRE) - Women who choose Brookhaven Retreat for their mental health and substance abuse therapy treatment have a greater chance of a successful recovery than those who select other residential treatment facilities, according to new research completed for the facility by The National Center on Addiction and Substance Abuse (CASA) at Columbia University.

According to the CASA report and survey of alumnae of Brookhaven Retreat, 73 percent said they were better able to function effectively at home or work once they completed their stay. Eighty percent had tried other treatment options prior to selecting Brookhaven Retreat, such as private therapy, drug therapy, psychosocial therapy, hospital inpatient and outpatient programs. Eighty-three percent said the treatment they received at Brookhaven Retreat was extremely helpful or very helpful in their recovery.

Located on 48 beautiful acres in the foothills of the Great Smoky Mountains, Brookhaven Retreat offers female-specific treatment and modern, holistic care with compassion and respect from a highly trained expert female staff of licensed therapists, physicians, registered nurses and nurse practitioners. It recently earned The Joint Commission's Gold Seal of Approval , which is awarded by this national healthcare accreditation organization to providers committed to standards for health care quality and safety, for the second time.

"Searching for a residential treatment facility can be a challenging process and it's often done during an emotional time," said Jacqueline Dawes, founder and owner of Brookhaven Retreat. "We at Brookhaven Retreat commissioned this research to discover how our approach to mental health and substance abuse therapy was performing. We are pleased to share that it is making a significant difference in the lives of our clients and their families."

As part of the survey, alumnae were asked the top three ways Brookhaven Retreat was instrumental in their recovery. Those responding listed the individual therapists and individual sessions; the environment; the activities and its unique offerings, including its recreation programs, equine-assisted therapy, outings and the Poncho program.

Brookhaven Retreat's unique Poncho program, which is a model for recovery that builds life skills and empowers individuals to prioritize their life needs in a healthy manner, received high marks from alumnae who said its sessions on identifying ways to stay emotionally and mentally healthy were extremely important to their recovery.

Brookhaven Retreat is a premier dual-diagnosis facility specializing in individualized treatment that links women with the appropriate support needed to begin healing. It is a fully accredited facility with both a mental health and a substance abuse license. For more information, call 877-817-3422 or visit www.brookhavenretreat.com.

About Brookhaven Retreat

Brookhaven Retreat is a unique, voluntary residential treatment facility specially designed to help women overcome emotional trauma or addiction challenges. The fully accredited and certified dual-diagnosis center is America's premier treatment center for emotional trauma and addiction and offers female-specific treatment. Located on 48 beautiful acres in the foothills of the Great Smoky Mountains, it offers modern, holistic care with compassion and respect from a highly trained expert staff of licensed therapists, physicians, registered nurses, nurse practitioners and licensed practical nurses. Visit www.brookhavenretreat.com for more information.

JPEG Headshot upon request

Brookhaven Retreat
Rebecca Oppenheimer, 404-367-2773
roppenheimer@golinharris.com


Related Business Wire News

Cerecor has been issued a US patent covering composition claims for its centrally-acting antitussive, FP01, currently in a Phase 2b study for the treatment of chronic cough.
Recap of stories on Business Wire related to Back to School.
Synergy Pharmaceuticals Inc. , a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financial results and business update for the second quarter ended June 30, 2013. Synergy is developing plecanatide for the ...
New market report names Quintiles as a preferred provider for Phase I studies.
Award-Winning Creative Strategist Brings Global View, Multi Category Experience and Proven Track Record to the Momentum-Fueled IPG Shop
Kobojo, the French developer that creates multi-platform games, has officially launched its latest game, Mutants: Genetic Gladiators. The free-to-play multi-player game is now available on Facebook.

 

NewsBlaze Writers Of The Month



Popular Stories This Month

newsletter logo

NewsBlaze
Copyright © 2004-2014 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site